Gadoxetic acid-enhanced magnetic resonance imaging can predict the pathologic stage of solitary hepatocellular carcinoma

Table 1 Comparison of demographic and other characteristics between the pathologic stage T2 and T1 groups, n (%)

Characteristics	pT2, n = 39	pT1, n = 75	P value
Age, mean ± SD	60.54 ± 11.17	58.32 ± 10.95	0.3101
Gender			0.375
Male	26 (66.7)	57 (76.0)
Female	13 (33.3)	18 (24.0)
Hepatitis virus subtype
HBV	21 (53.8)	50 (66.7)	0.223
HCV	15 (38.5)	21 (28.0)	0.292
HBV and HCV	3 (7.7)	3 (4.0)	0.385
Tumor marker
AFP	415.3 ± 1536.1	812.3 ± 5922.0	0.5683
CA-19-9	116.2 ± 606.2	14.1 ± 15.6	0.2998
Interval between the dates of imaging and surgery, mean ± SD	17.69 ± 30.80	18.09 ± 20.58	0.9419
METAVIR score of liver fibrosis			0.7852
F0-F3	28 (71.79)	52 (69.33)
F4	11 (28.21)	23 (30.67)

HBV and HCV: Hepatitis viruses B and C; AFP: Alpha-fetoprotein; CA-19-9: Cancer antigen 19-9; pT1: Pathologic stage T1; pT2: Pathologic stage T2.